Biodesign News
ASU research team working to decode TB
Grant to Advance Supercomputing for Human Health
Local teachers and students participate in Arizona’s largest summer high school bioscience internship program
Overview
Infectious disease causes 35 percent of deaths worldwide, and is the world’s biggest killer of children and young adults. Our researchers are focused on basic bacterial and viral infectious disease processes and the design and use of vaccines and protein therapeutics to combat infectious diseases. These include newly-emerging pathogens and potential biowarfare agents. We are devising new and effective ways of producing advanced vaccines and therapeutics, such as through the use of recombinant attenuated bacteria and viruses and genetically modified plants, and transferring this technology to the developing world to help fight diseases. Read More »
Center News
Arntzen to give lecture at the American Phytopathological Society
Global initiatives to improve human health will need more than scientific innovation— securing safe and affordable food and water systems are just as critical to long-term success. These issues will be among the topics discussed at this year’s special two-day plenary session of the American Phytopathological Society (APS), “Agriculture, Food Security and Public Health: Global Issues – Global Solutions.” Read More »
From friend to foe: Researchers use salmonella as a way to administer vaccines in the body
Researchers at the Biodesign Institute at Arizona State University have made a major step forward in their work to develop a biologically engineered organism that can effectively deliver an antigen in the body. The researchers report that they have been able to use live salmonella bacterium as the containment/delivery method for an antigen. Read More »
